Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Baotou Dongbao Bio-Tech Co.,Ltd
—
Baotou Dongbao Bio-Tech Co.,Ltd is led by CEO Fang Liu, employs 1,424 people, headquartered in Baotou, CN, publicly traded since 2011.
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) stock trades at $4.81 with a market capitalization of $2.93B. The stock is valued at a price-to-earnings (P/E) ratio of 54.78, price-to-book of 1.64, price-to-sales of 3.70. Over the past 52 weeks the stock has ranged between $4.46 and $6.82, and currently trades 29.5% below its 52-week high. It pays a dividend yielding 0.24%.
On profitability, Baotou Dongbao Bio-Tech Co.,Ltd generates a return on equity (ROE) of 3.17%, an operating margin of 6.07%, a net profit margin of 6.93%.
Official website: www.dongbaoshengwu.com
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) — frequently asked questions
What is Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) stock price today?
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) is currently trading at $4.81, down 2.63% today.
What is 300239.SZ P/E ratio?
Baotou Dongbao Bio-Tech Co.,Ltd's P/E ratio is 54.78. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 300239.SZ return on equity (ROE)?
Baotou Dongbao Bio-Tech Co.,Ltd's return on equity (ROE) is 3.17%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Baotou Dongbao Bio-Tech Co.,Ltd's market cap?
Baotou Dongbao Bio-Tech Co.,Ltd has a market capitalization of $2.93B.
Does 300239.SZ pay a dividend?
Yes. Baotou Dongbao Bio-Tech Co.,Ltd currently yields 0.24%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300239.SZ carry?
Baotou Dongbao Bio-Tech Co.,Ltd has a debt-to-equity ratio of 0.29. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300239.SZ's profit margin?
Baotou Dongbao Bio-Tech Co.,Ltd reports a net profit margin of 6.93% — the share of revenue left after every cost, including tax and interest.
What sector is 300239.SZ in?
Baotou Dongbao Bio-Tech Co.,Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300239.SZ listed on?
Baotou Dongbao Bio-Tech Co.,Ltd trades on SHZ under the ticker 300239.SZ.
What is 300239.SZ's 52-week range?
Over the last year Baotou Dongbao Bio-Tech Co.,Ltd has traded between $4.46 and $6.82.
Related — Stocks
Popular Stocks
Screens 300239.SZ currently matches
On the figures above, Baotou Dongbao Bio-Tech Co.,Ltd passes the filters for 10 of our ready-made screens, among them Low Debt Stocks, Penny Stocks, Stocks Under $5. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.